---
title: "Palivizumab - Respiratory Syncytial Virus Infection"
sidebar: mydoc_sidebar
permalink: db00110-mesh-d018357-1.html
toc: false 
---


Path ID: `DB00110_MESH_D018357_1`
{% include image.html url="images/db00110-mesh-d018357-1.png" file="db00110-mesh-d018357-1.png" alt="db00110-mesh-d018357-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069455">MESH:D000069455 </a> | palivizumab | Drug |
| <a href="https://identifiers.org/UniProt:P13843">UniProt:P13843 </a> | Fusion glycoprotein F0 | Protein |
| <a href="https://identifiers.org/GO:0019064">GO:0019064 </a> | fusion of virus membrane with host plasma membrane | BiologicalProcess |
| <a href="https://identifiers.org/GO:0046718">GO:0046718 </a> | viral entry into host cell | BiologicalProcess |
| <a href="https://identifiers.org/taxonomy:12814">taxonomy:12814 </a> | Respiratory syncytial virus | OrganismTaxon |
| <a href="https://identifiers.org/MESH:D018357">MESH:D018357 </a> | Respiratory syncytial virus infection | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Palivizumab | NEGATIVELY REGULATES | Fusion Glycoprotein F0 |
| Fusion Glycoprotein F0 | POSITIVELY REGULATES | Fusion Of Virus Membrane With Host Plasma Membrane |
| Fusion Glycoprotein F0 | POSITIVELY REGULATES | Viral Entry Into Host Cell |
| Viral Entry Into Host Cell | IN TAXON | Respiratory Syncytial Virus |
| Fusion Of Virus Membrane With Host Plasma Membrane | IN TAXON | Respiratory Syncytial Virus |
| Respiratory Syncytial Virus | CAUSES | Respiratory Syncytial Virus Infection |
|---------|-----------|---------|

Comment: This drug seems to be used for prophylaxis only because of its high cost and limited efficacy (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096974/#CR20). It's believed to elicit an antibody-dependent cell-mediated cytotoxicity activity in vivo ()https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000855/.

Reference: 
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201586/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201586/)
  - [https://go.drugbank.com/drugs/DB00110#BE0000686](https://go.drugbank.com/drugs/DB00110#BE0000686)
  - [https://en.wikipedia.org/wiki/Respiratory_syncytial_virus#Immunoprophylaxis](https://en.wikipedia.org/wiki/Respiratory_syncytial_virus#Immunoprophylaxis)
  - [https://en.wikipedia.org/wiki/Palivizumab](https://en.wikipedia.org/wiki/Palivizumab)
